Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic …
Biotechnology
US, Cambridge [HQ]
Balance Sheet
15 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | 481.00 | 393.00 | 281.00 | 287.00 | 420.00 | 1,079.00 | 1,386.00 | 1,262.00 | 1,994.00 | 1,574.00 | 2,395.00 | 3,407.00 | 3,643.00 | 3,546.00 | 3,829.00 | |
|
Current
|
293.00 | 370.00 | 266.00 | 228.00 | 358.00 | 1,026.00 | 1,358.00 | 989.00 | 1,782.00 | 1,209.00 | 1,733.00 | 2,159.00 | 2,868.00 | 2,692.00 | 2,982.00 | |
| Cash And Equivalents | 137.00 | 74.00 | 70.00 | 51.00 | 53.00 | 881.00 | 1,280.00 | 193.00 | 645.00 | 420.00 | 547.00 | 496.00 | 819.00 | 866.00 | 812.00 | |
| Assets | 481.00 | 393.00 | 281.00 | 287.00 | 420.00 | 1,079.00 | 1,386.00 | 1,262.00 | 1,994.00 | 1,574.00 | 2,395.00 | 3,407.00 | 3,643.00 | 3,546.00 | 3,829.00 | |
| Accounts Receivables (AR) | - - | - - | - - | 1.00 | -4.00 | -35.00 | 31.00 | -15.00 | -10.00 | 15.00 | -24.00 | -56.00 | -101.00 | -45.00 | -87.00 | |
| Inventory | - - | -226.00 | -142.00 | - - | - - | - - | - - | - - | - - | 24.00 | 56.00 | 92.00 | 122.00 | 128.00 | 89.00 | |
| Short Term Investments | 143.00 | 158.00 | 76.00 | 71.00 | 192.00 | 94.00 | 51.00 | 433.00 | 1,045.00 | 664.00 | 988.00 | 1,377.00 | 1,615.00 | 1,326.00 | 1,626.00 | |
| Other Current Assets | 6.00 | 349.00 | 260.00 | 2.00 | 3.00 | 9.00 | 18.00 | 23.00 | 44.00 | 83.00 | 98.00 | 90.00 | 111.00 | 132.00 | 126.00 | |
|
Non Current
|
187.00 | 22.00 | 15.00 | 58.00 | 61.00 | 53.00 | 27.00 | 273.00 | 211.00 | 365.00 | 661.00 | 1,247.00 | 774.00 | 854.00 | 847.00 | |
| Property, Plant, Equipment (Net) | 18.00 | 18.00 | 14.00 | 19.00 | 16.00 | 21.00 | 27.00 | 114.00 | 181.00 | 320.00 | 646.00 | 706.00 | 733.00 | 738.00 | 725.00 | |
|
Intangible Assets
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 264.00 | 697.00 | |
| Goodwill | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Long Term Investments | 6.00 | 3.00 | - - | 38.00 | 45.00 | 279.00 | 251.00 | 8.00 | 30.00 | 44.00 | 14.00 | 40.00 | 40.00 | -2,559.00 | 51.00 | |
| Other Non Current Assets | 151.00 | 120.00 | 114.00 | - - | - - | 279.00 | -251.00 | 150.00 | - - | - - | - - | 500.00 | - - | 115.00 | -3,526.00 | |
| Liabilities | 303.00 | 235.00 | 163.00 | 153.00 | 150.00 | 143.00 | 121.00 | 342.00 | 228.00 | 272.00 | 956.00 | 2,390.00 | 3,055.00 | 3,704.00 | 4,050.00 | |
|
Current
|
110.00 | 231.00 | 18.00 | 153.00 | 150.00 | 143.00 | 121.00 | 192.00 | 198.00 | 242.00 | 956.00 | 1,127.00 | 1,191.00 | 767.00 | 967.00 | |
| Accounts Payable | 9.00 | -3.00 | -3.00 | -1.00 | 1.00 | 8.00 | 1.00 | 10.00 | -4.00 | 15.00 | 36.00 | 117.00 | 88.00 | 191.00 | 80.00 | |
| Short Term Debt | -4.00 | -11.00 | -62.00 | 4.00 | 2.00 | 5.00 | 6.00 | 11.00 | 10.00 | 62.00 | 303.00 | 329.00 | 321.00 | 41.00 | 96.00 | |
| Deferred Revenue | 81.00 | 211.00 | 62.00 | 132.00 | 126.00 | 66.00 | 68.00 | 82.00 | 84.00 | 3.00 | 396.00 | 352.00 | 301.00 | 42.00 | 102.00 | |
| Tax Payable | 5.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Current Liabilities | 10.00 | 11.00 | 12.00 | 12.00 | 15.00 | 56.00 | 29.00 | 43.00 | 74.00 | 116.00 | 206.00 | 393.00 | 494.00 | 585.00 | 713.00 | |
|
Non Current
|
192.00 | 3.00 | 145.00 | 105.00 | 96.00 | 47.00 | 59.00 | 150.00 | 30.00 | 30.00 | 603.00 | 1,262.00 | 1,863.00 | 2,936.00 | 3,082.00 | |
| Long Term Debt | - - | - - | - - | - - | - - | -31.00 | - - | 150.00 | 30.00 | 30.00 | 276.00 | 191.00 | 675.00 | 1,278.00 | 2,343.00 | |
| Leasing Obligations | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 303.00 | 329.00 | 321.00 | 303.00 | 243.00 | |
| Deferred Non Current Tax Liabilities | - - | - - | - - | - - | - - | 31.00 | - - | -52.00 | -47.00 | -5.00 | - - | -225.00 | -152.00 | - - | 243.00 | |
| Other Non Current Liabilities | 2.00 | -126.00 | 4.00 | 4.00 | 2.00 | 5.00 | 6.00 | 3.00 | 4.00 | 4.00 | -594.00 | 1,071.00 | 1,188.00 | 1,464.00 | 308.00 | |
| Equity | 177.00 | 158.00 | 117.00 | 134.00 | 270.00 | 936.00 | 1,264.00 | 920.00 | 1,766.00 | 1,301.00 | 1,438.00 | 1,016.00 | 588.00 | -158.00 | -220.00 | |
| Stockholders' Equity | 177.00 | 158.00 | 117.00 | 134.00 | 270.00 | 936.00 | 1,264.00 | 920.00 | 1,766.00 | 1,301.00 | 1,438.00 | 1,016.00 | 588.00 | -158.00 | -220.00 | |
| Retained Earnings | -299.00 | -343.00 | -400.00 | -507.00 | -596.00 | -956.00 | -1,246.00 | -1,656.00 | -2,147.00 | -2,840.00 | -3,727.00 | -4,585.00 | -5,438.00 | -6,569.00 | -7,009.00 | |
| Common Stock | - - | - - | - - | - - | - - | - - | - - | - - | - - | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Preferred Stock | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Profit | -47.00 | -43.00 | -57.00 | -106.00 | -89.00 | -360.00 | -290.00 | -410.00 | -490.00 | -761.00 | -886.00 | -858.00 | -852.00 | -1,131.00 | -440.00 | |
| Dividends | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Minority Interest | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Stockholders' Equity | 476.00 | 500.00 | 518.00 | 624.00 | 846.00 | 1,843.00 | 2,506.00 | 2,609.00 | 3,947.00 | 4,175.00 | 5,201.00 | 5,644.00 | 6,058.00 | 6,454.00 | 6,811.00 | |
| Loss Other Compr. Income | - - | - - | - - | 15.00 | 19.00 | 48.00 | 4.00 | -33.00 | -34.00 | -33.00 | -36.00 | -43.00 | -33.00 | -44.00 | -23.00 |